EXCEL: Technology and Exercise Adherence
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04790578 |
Recruitment Status :
Recruiting
First Posted : March 10, 2021
Last Update Posted : April 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cancer | Device: ZoeInsights Application Behavioral: EXCEL Exercise Class | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 140 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Participants of the EXCEL study will be randomly allocated to either receiving the ZoeInsigths application during their 12 week baseline class + 12 week follow-up (intervention) or only receiving the 12 week baseline class (waitlist control). Those in the waitlist control group will be offered the ZoeInsights application at the end of the 24-week study period after completing their 24-week measures. Block randomization will be used so that all EXCEL participants in a single group-based class will be assigned to either the intervention or waitlist control group. |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Outcome assessors will be unaware of the intervention the participants received. Due to the nature of the intervention (a eHealth application) participants can't be blinded to the intervention. Furthermore, due to the intention to integrate the application as part of extended support provided in the EXCEL program, exercise class instructors (care providers) will be made aware of participant group assignment. The research coordinator will also be aware of the intervention of each participant to aid in troubleshooting with the ZoeInsights application. |
Primary Purpose: | Supportive Care |
Official Title: | Technology to Support Exercise Adherence in Project EXCEL Participants |
Actual Study Start Date : | April 1, 2021 |
Estimated Primary Completion Date : | December 30, 2022 |
Estimated Study Completion Date : | June 30, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: ZoeInsights Application Arm
Participants will receive free access to the ZI app for the 12-week intervention. After completing initial set-up, participants will be asked to record physical activity and symptoms regularly via scheduled in-app routines. Further use of ZI (eg. Custom daily routines, additional graphing, medication tracking, accessing linked health resources) during the intervention will be possible ad libitum. After the initial 12-weeks of the EXCEL+ZI intervention, participants have continued free access to the ZI app for up to 1 year.
|
Device: ZoeInsights Application
ZI is designed to promote PA behavior change and maintenance via self-monitoring of PA, symptoms, and other health data. Additional information for using ZI will be provided via a PDF-based user guide on installing and using the application, a live instructional webinar hosted by ZI developer Hanalytics Solutions, and access to continued support via email/telephone communication with study staff as well as Hanalytics Solutions. Reminders to complete self-monitoring tasks will be provided using daily push notifications scheduled according to participant preferences. Automatic graphs will be generated and displayed within the app to allow participants to visualize trends in physical activity, symptoms, and other health data. ZI can be accessed via a web browser on any device that is connected to the internet (e.g. computer, laptop, tablet, smartphone), or via a native android or iOS mobile application on a smartphone or tablet. Behavioral: EXCEL Exercise Class The group based remote exercise program is delivered twice a week over the Zoom application. Classes are one hour long with a ten minute warm up, 40 minute strength and conditioning focused exercise circuits, and a ten minute stretching. Each class is followed by additional time to provide participants with an opportunity to interact with each other, fostering social support. |
Active Comparator: Waitlist control
During the 12-week intervention the participants will only take part in an online delivered EXCEL exercise class and will not have access to the ZI app. After completion of the 24-week test, the participants will be granted access to the ZI app.
|
Behavioral: EXCEL Exercise Class
The group based remote exercise program is delivered twice a week over the Zoom application. Classes are one hour long with a ten minute warm up, 40 minute strength and conditioning focused exercise circuits, and a ten minute stretching. Each class is followed by additional time to provide participants with an opportunity to interact with each other, fostering social support. |
- Objective Physical Activity Minutes Per Week [ Time Frame: Measured continuously from baseline to 24 weeks ]
Change in activity levels from pre to post; Number of participants meeting Guidelines for Physical Activity of 90 minutes per week of moderate to vigorous intensity exercise, based on accelerometer data from commercially-available activity tracker.
For the activity tracker each minute in the 55-70 percent age predicted HRmax will be evaluated as moderate intensity and above 70 percent of HRmax will be evaluated as vigorous intensity.
Vigorous intensity minutes of physical activity will be doubled and added with moderate intensity minutes to obtain moderate to vigorous physical activity (MVPA) minutes.
- Subjective Physical Activity Minutes Per Week [ Time Frame: Self-reported at baseline, week 4, week 12, and week 24 ]Change in Physical Activity minutes per week, based on modified Godin Leisure Time Exercise Questionnaire (mGLTEQ). In the mGLTEQ all dimensions (strenuous exercise, moderate exercise, mild exercise, resistance training, and flexibility) will be looked at separately and weekly minutes will be calculated by multiplying duration times frequency of sessions. Vigorous intensity minutes of exercise will be doubled and added with moderate intensity minutes to obtain moderate to vigorous physical activity (MVPA) minutes. Higher scores are better, indicating more minutes of MVPA were accumulated.
- EXCEL class attendance [ Time Frame: Potential class data in EXCEL baseline and maintenance classes will be recorded, and input into REDCap, from week 1-12 (baseline); and 12-24 (maintenance, optional) ]Class attendance (up to 2 x per week) during weeks 1-12 will be recorded by the EXCEL class lead, and input into REDCap. In addition, attendance at subsequent EXCEL maintenance programs (up to week 24) will be recorded
- ZI application usage [ Time Frame: Continuous measurement from baseline to 24 weeks ]Measured directly through the app as logins, tasks completed, pages visited, additional use, and continued usage habits during the maintenance phase
- Participant Satisfaction [ Time Frame: Completed at week 4, 12, and 24 ]Change in the mobile app usability questionnaire (MAUQ) score. Scores for each item range from 0 (strongly disagree) to 7 (strongly agree), with higher scores indicating greater satisfaction.
- Body Composition [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in body mass index (BMI)
- Aerobic Endurance [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in 6-minute walk test (m) or 2 minute step test (steps) results
- Upper extremity grip strength [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in hand-grip dynamometry (kg)
- Functional performance test [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in sit-to-stand (number of repetitions in 30 seconds)
- Upper extremity flexibility [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in active shoulder flexion range of motion (degrees)
- Lower extremity flexibility [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in sit-and-reach test (cm)
- Balance [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in one legged stance test (seconds)
- Cancer related symptoms [ Time Frame: Assessed at baseline and weeks 4, 8, 12, 16, 20, 24 ]Change in Edmonton Symptom Assessment Scale. Scores range from 0 to 10 for each item, with a total score ranging from 0 to 100. Higher scores indicate higher symptom burden.
- General Health-related Quality of Life [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in EuroQual - 5 Dimensions (EQ-5D) tool. Scores for each item range from 1 to 5, with lower scores indicating better quality of life.
- Fatigue [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]
Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale
- scale is from 0-4, where 0 means "not at all" and 4 means "very much".
- General well-being [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]
Change in Functional Assessment of Cancer Therapy - General subscale
- scale is from 0-4, where 0 means "not at all" and 4 means "very much".
- Cognition [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]
Change in Functional Assessment of Cancer Therapy - Cognitive subscale
- scale is from 0-4, where 0 means "never" and 4 means "several times a day" (experiencing symptoms).
- Barriers and facilitators to exercise participation [ Time Frame: Assessed at baseline,12-weeks (post-intervention), and 24 weeks (follow-up) ]Change in Exercise Barriers and Facilitators questionnaire
- Exercise adherence [ Time Frame: Continuous measurement from baseline to 24 weeks ]Adherence to exercise programming (attendance at sessions)
- Participant perceptions of using the ZI application [ Time Frame: At 12 and 24 weeks ]A purposive sample of participants from the intervention group (n=10-20) will be invited to participate in semi-structured one-on-one interviews.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
- Have a cancer diagnosis
- Be over the age of 18 years
- Be able to participate in mild levels of activity as a minimum (to be assessed during screening via the Physical Activity Readiness Questionnaire)
- Be pre-treatment, or receiving active cancer treatment, or have received cancer treatment within the past three year
- Be able to provide informed written consent in English
- Have access to internet service that can support video calling
- Be signed up for the EXCEL baseline class
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04790578
Contact: Manuel Ester | +17788144605 | manuel.ester@ucalgary.ca |
Canada, Alberta | |
University of Calgary | Recruiting |
Calgary, Alberta, Canada, T2N 1N4 | |
Contact: Julianna Dreger 4032108482 |
Responsible Party: | University of Calgary |
ClinicalTrials.gov Identifier: | NCT04790578 |
Other Study ID Numbers: |
HREBA.CC-20-0283 |
First Posted: | March 10, 2021 Key Record Dates |
Last Update Posted: | April 7, 2022 |
Last Verified: | March 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Exercise mHealth |